FDA's multi-pronged approach helps meet the challenge of bringing new and innovative antibiotics to patients who need them

FDA's official blog brought to you from FDA's senior leadership and staff stationed at home and abroad - sharing news, background, announcements and other information about the work done at the FDA on behalf of the American public.

By: Edward M. Cox, MD, MPH

With a growing number of infections becoming increasingly resistant to our current arsenal of antibiotics, developing new antibiotics to treat serious or life-threatening infections has become a key priority.

Food & Drug Administration (FDA)

News Well, Blog, Food & Drug Administration (FDA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lBkqry